BBVA Argentina (BBAR) Q2 2026 Earnings Call Transcript

BBVA Argentina reported inflation-adjusted Q2’26 net income of ARS 131.6B, up 44.6% QoQ, with ROE rising to 12.2% (from 8.3% in Q1) as operating income stayed stable in a lower-inflation environment. Asset quality remains a key risk: NPL ratio rose to 6.09% (+49 bps QoQ) and cost of risk was 7.13%, but management guided for peak delinquency in Q2 and expects improvement toward a 5.5% year-end NPL target and ~6.5% full-year cost of risk. The bank reiterated 2026 guidance of ~10% real loan book growth and low-teens real ROE, while warning of moderate NIM pressure in pesos as rates decline; liquidity (45.5%) and capital strength (CET1/reg. capital ratio 18.8%, 128.7% above minimum) remain supportive.

Analysis

BBAR’s setup is less about near-term earnings upside and more about mix quality. The bank is shifting toward secured retail, payroll-linked lending, and commercial credit with better visibility, which should reduce realized losses faster than headline loan growth alone suggests. The catch is that as Argentina normalizes, the same decline in inflation/rates that helps activity also mechanically compresses nominal NII, so the valuation case hinges on fee growth and lower credit costs offsetting margin pressure.

Second-order, the public-sector bond book is effectively a carry buffer for the next 1-3 quarters, but it also increases sovereign-duration sensitivity if policy credibility wobbles. Mortgage acceleration and FX lending could lift volumes, yet they only matter if deposit growth and dollar liquidity remain stable; otherwise the bank is forced into a lower-return balance-sheet mix. The market should reward the likely Q3 deceleration in NPLs, but that is a months-long catalyst, not a days-long thesis.

Contrarian risk: investors may be underestimating how fragile the unsecured consumer book still is. If personal loans and cards do not show a clear step-down in arrears, the apparent peak in credit costs becomes a temporary plateau and the stock should de-rate as a macro-beta bank rather than a clean compounder. Falsifiers are simple: if Q3 NPLs stay near 6% or real NIM falls more than management’s implied 100-125 bps by year-end, the recovery story is too early.

Key Decisions for Investors

• Small tactical long BBAR for 4-8 weeks only; use post-earnings weakness to enter, targeting a 10-15% move if Q3 asset quality prints sequentially better. Keep size modest because this is a macro beta trade, not a franchise re-rating.
• If options are available, prefer a defined-risk BBAR call spread over outright stock for 3-6 months; the upside is tied to a narrow catalyst window, while sovereign and margin risk cap the standalone equity payoff.
• Do not chase into strength unless Q3 early-delinquency data confirms the turn; add only if NPLs and cost of risk roll over sequentially. If that does not happen, treat the stock as range-bound and harvest gains.
• Use a hard risk trigger: reduce/exit if BBAR reports another quarter with NPLs above ~6% or if management is forced to lower full-year cost-of-risk guidance. That would invalidate the near-term inflection thesis.
• Favor BBAR over broader Argentine exposure only if you want direct leverage to normalization; otherwise stay on the sidelines until the mortgage/secured-lending mix proves it can offset NIM compression.